170 related articles for article (PubMed ID: 28490575)
1. EZH2 Regulates the Developmental Timing of Effectors of the Pre-Antigen Receptor Checkpoints.
Jacobsen JA; Woodard J; Mandal M; Clark MR; Bartom ET; Sigvardsson M; Kee BL
J Immunol; 2017 Jun; 198(12):4682-4691. PubMed ID: 28490575
[TBL] [Abstract][Full Text] [Related]
2. Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic Plasticity.
Chen NM; Neesse A; Dyck ML; Steuber B; Koenig AO; Lubeseder-Martellato C; Winter T; Forster T; Bohnenberger H; Kitz J; Reuter-Jessen K; Griesmann H; Gaedcke J; Grade M; Zhang JS; Tsai WC; Siveke J; Schildhaus HU; Ströbel P; Johnsen SA; Ellenrieder V; Hessmann E
Gastroenterology; 2017 May; 152(6):1507-1520.e15. PubMed ID: 28188746
[TBL] [Abstract][Full Text] [Related]
3. EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB-1 proliferation index.
Purkait S; Sharma V; Jha P; Sharma MC; Suri V; Suri A; Sharma BS; Sarkar C
Neuropathology; 2015 Oct; 35(5):421-31. PubMed ID: 26096306
[TBL] [Abstract][Full Text] [Related]
4. Ezh2 Regulates Activation-Induced CD8
Chen G; Subedi K; Chakraborty S; Sharov A; Lu J; Kim J; Mi X; Wersto R; Sung MH; Weng NP
Front Immunol; 2018; 9():549. PubMed ID: 29632530
[TBL] [Abstract][Full Text] [Related]
5. Enhancer of zeste homolog 2 (
Dudakovic A; Camilleri ET; Paradise CR; Samsonraj RM; Gluscevic M; Paggi CA; Begun DL; Khani F; Pichurin O; Ahmed FS; Elsayed R; Elsalanty M; McGee-Lawrence ME; Karperien M; Riester SM; Thaler R; Westendorf JJ; van Wijnen AJ
J Biol Chem; 2018 Aug; 293(33):12894-12907. PubMed ID: 29899112
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas.
Makk E; Bohonyi N; Oszter A; Éles K; Tornóczky T; Tóth A; Kálmán E; Kovács K
Pathol Oncol Res; 2023; 29():1611547. PubMed ID: 38146588
[No Abstract] [Full Text] [Related]
7. The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy.
Zingg D; Arenas-Ramirez N; Sahin D; Rosalia RA; Antunes AT; Haeusel J; Sommer L; Boyman O
Cell Rep; 2017 Jul; 20(4):854-867. PubMed ID: 28746871
[TBL] [Abstract][Full Text] [Related]
8. FOXA1 antagonizes EZH2-mediated CDKN2A repression in carcinogenesis.
Zhang Y; Tong T
Biochem Biophys Res Commun; 2014 Oct; 453(1):172-8. PubMed ID: 25264199
[TBL] [Abstract][Full Text] [Related]
9. Histone methyltransferase Ezh2 negatively regulates NK cell terminal maturation and function.
Yu M; Su Z; Huang X; Zhou Y; Zhang X; Wang B; Wang Z; Liu Y; Xing N; Xia M; Wang X
J Leukoc Biol; 2021 Dec; 110(6):1033-1045. PubMed ID: 34425630
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Control of
Koss B; Shields BD; Taylor EM; Storey AJ; Byrum SD; Gies AJ; Washam CL; Choudhury SR; Hyun Ahn J; Uryu H; Williams JB; Krager KJ; Chiang TC; Mackintosh SG; Edmondson RD; Aykin-Burns N; Gajewski TF; Wang GG; Tackett AJ
Cancer Res; 2020 Nov; 80(21):4707-4719. PubMed ID: 33004350
[TBL] [Abstract][Full Text] [Related]
11. Thymocyte proliferation induced by pre-T cell receptor signaling is maintained through polycomb gene product Bmi-1-mediated Cdkn2a repression.
Miyazaki M; Miyazaki K; Itoi M; Katoh Y; Guo Y; Kanno R; Katoh-Fukui Y; Honda H; Amagai T; van Lohuizen M; Kawamoto H; Kanno M
Immunity; 2008 Feb; 28(2):231-45. PubMed ID: 18275833
[TBL] [Abstract][Full Text] [Related]
12. Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity.
Yin J; Leavenworth JW; Li Y; Luo Q; Xie H; Liu X; Huang S; Yan H; Fu Z; Zhang LY; Zhang L; Hao J; Wu X; Deng X; Roberts CW; Orkin SH; Cantor H; Wang X
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15988-93. PubMed ID: 26668377
[TBL] [Abstract][Full Text] [Related]
13. Enhancer of zeste homolog 2 depletion induces cellular senescence via histone demethylation along the INK4/ARF locus.
Jie B; Weilong C; Ming C; Fei X; Xinghua L; Junhua C; Guobin W; Kaixiong T; Xiaoming S
Int J Biochem Cell Biol; 2015 Aug; 65():104-12. PubMed ID: 26004298
[TBL] [Abstract][Full Text] [Related]
14. Ezh2 programs T
Li F; Zeng Z; Xing S; Gullicksrud JA; Shan Q; Choi J; Badovinac VP; Crotty S; Peng W; Xue HH
Nat Commun; 2018 Dec; 9(1):5452. PubMed ID: 30575739
[TBL] [Abstract][Full Text] [Related]
15. EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop.
Béguelin W; Rivas MA; Calvo Fernández MT; Teater M; Purwada A; Redmond D; Shen H; Challman MF; Elemento O; Singh A; Melnick AM
Nat Commun; 2017 Oct; 8(1):877. PubMed ID: 29026085
[TBL] [Abstract][Full Text] [Related]
16. EZH2 regulates the expression of p16 in the nasopharyngeal cancer cells.
Zhong J; Min L; Huang H; Li L; Li D; Li J; Ma Z; Dai L
Technol Cancer Res Treat; 2013 Jun; 12(3):269-74. PubMed ID: 23289480
[TBL] [Abstract][Full Text] [Related]
17. DNA-PK-mediated phosphorylation of EZH2 regulates the DNA damage-induced apoptosis to maintain T-cell genomic integrity.
Wang Y; Sun H; Wang J; Wang H; Meng L; Xu C; Jin M; Wang B; Zhang Y; Zhang Y; Zhu T
Cell Death Dis; 2016 Jul; 7(7):e2316. PubMed ID: 27468692
[TBL] [Abstract][Full Text] [Related]
18. Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.
Gnani D; Romito I; Artuso S; Chierici M; De Stefanis C; Panera N; Crudele A; Ceccarelli S; Carcarino E; D'Oria V; Porru M; Giorda E; Ferrari K; Miele L; Villa E; Balsano C; Pasini D; Furlanello C; Locatelli F; Nobili V; Rota R; Leonetti C; Alisi A
Cell Death Differ; 2017 May; 24(5):889-902. PubMed ID: 28338656
[TBL] [Abstract][Full Text] [Related]
19. Histone Methyltransferase Enhancer of Zeste Homolog 2-Mediated ABCA1 Promoter DNA Methylation Contributes to the Progression of Atherosclerosis.
Lv YC; Tang YY; Zhang P; Wan W; Yao F; He PP; Xie W; Mo ZC; Shi JF; Wu JF; Peng J; Liu D; Cayabyab FS; Zheng XL; Tang XY; Ouyang XP; Tang CK
PLoS One; 2016; 11(6):e0157265. PubMed ID: 27295295
[TBL] [Abstract][Full Text] [Related]
20. Normal formation of a vertebrate body plan and loss of tissue maintenance in the absence of ezh2.
San B; Chrispijn ND; Wittkopp N; van Heeringen SJ; Lagendijk AK; Aben M; Bakkers J; Ketting RF; Kamminga LM
Sci Rep; 2016 May; 6():24658. PubMed ID: 27145952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
